Skip to main content
. 2020 Oct 16;12:1759720X20959575. doi: 10.1177/1759720X20959575

Table 3.

Main studies reporting anakinra administration in pediatric Behçet disease.

Type of study Patients (n) Dose Response Adverse events Follow up (months)
Bilgner et al.41 Case report 1 (also affected by FMF) 1 mg/kg/day Remission NA 18
Urgulu et al.42 Letter to the editor 1 2 mg/kg/day Persistent uveitis NA 1
Cantarini et al.40 Case series 1 2 mg/kg/day and after 4 months 2.5 mg/kg/day for a relapse Partial response NA 9

FMF, familial Mediterranean fever; NA, not available.